NCT00174369 MEK Inhibitor PD-325901 To Treat Advanced Non-Small Cell Lung Cancer Status TERMINATED Phase PHASE2
NCT00174356 PH 1 Evaluation Of Oral CI-1033 In Combination With Paclitaxel/ Carboplatin As 1st Line Chemotherapy In NSCLC Patients Status COMPLETED Phase PHASE1
NCT00174343 Exemestane As Treatment In Neoadjuvant Setting For Operable Breast Cancer Patients Status COMPLETED Phase PHASE2
NCT00174317 Celecoxib Versus Diclofenac In The Treatment Of Osteoarthritis Of The Hip Status COMPLETED Phase PHASE4
NCT00174291 Prevention of Growth Retardation by Early Treatment With Growth Hormone (GH) in Children With CJA Treated by Corticosteroid Therapy Status TERMINATED Phase PHASE3
NCT00174278 Treatment With Recombinant Human Growth Hormone Genotonorm (Registered) In Children With Short Stature Secondary Status COMPLETED Phase PHASE3
NCT00174252 Study Aimed At Improving Height With Genotonorm In Children Born Little And/Or Light With Growth Retardation At The Age Status COMPLETED Phase PHASE3
NCT00174239 Study Of Cabaser and Sinemet CR For The Treatment Of Nighttime Symptoms Associated With Parkinson's Disease. Status TERMINATED Phase PHASE4
NCT00174226 Treatment of Adult ADHD With Atomoxetine or Atomoxetine and Buspar Status COMPLETED Phase PHASE2
NCT00174200 Study To Assess Differential Sensitivity Of 2 Spatial Working Memory Tests In Schizophrenics Treated With Risperidone Status COMPLETED Phase NA
NCT00174187 Treatment With Recombinant Human Growth Hormone (GH) in Children With Short Stature Secondary to a Long Term Corticoid Therapy Status TERMINATED Phase PHASE3
NCT00172419 The Effects of Atorvastatin on Vulnerable Plaques in Untreated Dyslipidemic Patients. Status COMPLETED Phase NA
NCT00171366 A Study Comparing the Response of Patients With Hypertension to Amlodipine or Amlodipine Plus Benazepril. Status COMPLETED Phase PHASE3
NCT00169988 Antidepressant and Antipsychotic to Treat Attenuated Positive and Negative Symptoms Status COMPLETED Phase NA
NCT00168896 A Study for Small Cell Lung Cancer (SCLC) in Extensive Disease Stage Status UNKNOWN Phase PHASE2/PHASE3
NCT00168155 Study of 5-FU + Leucovorin + CPT-11 in Patients With Resectable Liver Metastases From Colorectal Adenocarcinoma Status COMPLETED Phase PHASE2
NCT00163618 Study to Investigate the Seropersistence of TBE Virus Antibodies Approx. 3 Years After a Booster Vaccination With FSME-IMMUN 0.25 mL JUNIOR in Children Status COMPLETED Phase N/A
NCT00163540 Immunogenicity and Safety Study of a Third Vaccination With FSME-IMMUN 0.5 mL in Subjects Previously Vaccinated According to a Rapid Immunization Schedule (Follow-up to Study 225) Status COMPLETED Phase PHASE4
NCT00163527 Efficacy and Safety of Oral Roflumilast Taken With Low Dose Inhaled Corticosteroids in Patients With Asthma (12 to 70 y) (BY217/M2-013) Status COMPLETED Phase PHASE3